Eli Lilly & Co. (LLY)
1007.77
-7.98
(-0.79%)
USD |
NYSE |
May 14, 16:00
1005.58
-2.19
(-0.22%)
After-Hours: 18:46
Eli Lilly EPS Diluted (Quarterly) : 8.255 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Merck & Co., Inc. | -1.715 |
| Pfizer Inc. | 0.4688 |
| Bristol Myers Squibb Co. | 1.308 |
| Nektar Therapeutics | -1.815 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.396B |
| Revenue (Quarterly) | 19.80B |
| Total Expenses (Quarterly) | 12.40B |
| Enterprise Value | 943.87B |
| Gross Profit Margin (Quarterly) | 81.93% |
| Profit Margin (Quarterly) | 37.36% |
| Earnings Yield | 2.76% |
| Operating Earnings Yield | 3.73% |
| Normalized Earnings Yield | 2.912 |